SCHEMBL4762152

SCHEMBL4762152

COc1ccc(C(=O)N[C@@H](CC(C)C)C(=O)N(C2CCCNCC2=O)S(=O)(=O)c2ccc(F)cc2)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.39
ROCK1 Q13464 3/20 0.39
TAS1R3 Q7RTX0 2/20 0.39
TAS1R1 Q7RTX1 2/20 0.39
BCL2L1 Q07817 2/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA9 Q16790 2/20 0.37
MAPK14 Q16539 1/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2C9 P11712 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
CTSL P07711 1/20 0.35
CYP2D6 P10635 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4762084 0.93 TAS1R3 (0.39) TAS1R3TAS1R1BCL2L1CA12CA1
SCHEMBL4762088 0.93 TAS1R3 (0.39) TAS1R3TAS1R1BCL2L1CA12CA1
SCHEMBL4823328 0.80 CTSK (0.46) TAS1R3TAS1R1CTSL
SCHEMBL6765735 0.80 CTSK (0.46) TAS1R3TAS1R1
SCHEMBL4838791 0.80 CTSK (0.46) TAS1R3TAS1R1
SCHEMBL6590279 0.80 TAS1R3 (0.39) TAS1R3TAS1R1CTSLPSEN1PSEN2
SCHEMBL6590283 0.80 TAS1R3 (0.39) TAS1R3TAS1R1CTSLPSEN1PSEN2
SCHEMBL7036904 0.80 PSEN1 (0.38) MEN1KMT2APSEN1PSEN2APH1B
SCHEMBL4763320 0.79 CTSL (0.37) CA12CA1CA9MAPK14CTSL
SCHEMBL4763065 0.78 MMP2 (0.37) TAS1R3TAS1R1KMT2ACTSLPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1320370-A4 METHOD OF TREATMENT SMITHKLINE BEECHAM CORP (US) 2008-10-22 EP disclosed
EP-1307204-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-06-02 EP disclosed
EP-1320370-A1 METHOD OF TREATMENT SmithKline Beecham Corporation (US) 2003-06-25 EP disclosed
EP-1307204-A1 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2003-05-07 EP disclosed
WO-2002017924-A1 METHOD OF TREATMENT SMITHKLINE BEECHAM CORPORATION (GB) 2002-03-07 WO disclosed
WO-2001095911-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-20 WO disclosed